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96ABSTRACT
Background. QT interval prolongation has frequently been observed in patients with
advanced liver disease. We investigated the inﬂuence of inhalation anesthetics on the
corrected QT (QTc) interval prolongation during surgery in patients undergoing living-
donor liver transplantation.
Methods. Our study included 43 patients who were assigned to 2 groups: sevoﬂurane
(n ¼ 22) or desﬂurane anesthesia (n ¼ 21). QTc intervals were measured at perioperative
determined time points and calculated using Fridericia’s formula.
Results. Intraoperative QTc intervals increased during the peri-intubation period versus
baseline (P ¼ .003) and were prolonged during the peri-reperfusion period (P < .001).
However, there was no signiﬁcant difference in intraoperative QTc interval changes
between patients given sevoﬂurane or desﬂurane (P ¼ .59).
Conclusions. In this prospective observational study, there was no signiﬁcant difference
in QTc intervals between sevoﬂurane and desﬂurane. QTc intervals increased during
intubation and reperfusion relative to preoperative values in patients given either sevo-
ﬂurane or desﬂurane.*Address correspondence to Hyun Joo Kim, MD, Assistant
Professor, Department of Anesthesiology and Pain Medicine,
Yonsei University College of Medicine, Seoul 120-752, Korea.
E-mail: jjollong@gmail.comCORRECTED QT (QTc) interval prolongation, whichincreases the risk of life-threatening arrhythmias, such
as torsade de pointes, has been reported to be associated
with liver diseases, such as liver cirrhosis [1]. The mecha-
nism of QTc interval prolongation in patients with liver
disease is unknown, but autonomic dysfunction, induced by
altered concentrations of circulating neurotransmitters, has
been suggested as a major cause because QTc interval
prolongation typically improves after liver transplantation
[1,2]. Speciﬁcally, QTc interval prolongation is observed in
half of patients who have end-stage liver disease and are
scheduled for living-donor liver transplantation [3].
Furthermore, in these vulnerable patients, QTc interval
prolongation is aggravated during surgery, resulting in
adverse cardiovascular events because surgical stimulation
and tracheal intubation cause further disturbances, such as
electrolyte imbalance, drugs, and sympathetic activation
[4e7]. Thus, methods of minimizing QTc interval6
.org/10.1016/j.transproceed.2015.12.034prolongation in patients undergoing liver transplantation
should be identiﬁed.
Inhalational anesthetics such as sevoﬂurane and desﬂurane
have been reported to prolong the QTc interval during
anesthesia [8e11]. Although desﬂurane is thought to increase
the QTc interval more than sevoﬂurane by inducing sympa-
thetic hyperactivity [12], this remains controversial [13,14].
Moreover, these previous studies targeted patients who did
not have risk factors for QTc interval prolongation, so the
effect of inhalational agents on the QTc interval in patients
who have cardiac risk factors may be different. To our
knowledge, no study has compared the effects of inhalationalª 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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SEVOFLURANE AND DESFLURANE 97agents on the QTc interval prolongation in patients under-
going liver transplantation. Thus, we hypothesized that des-
ﬂurane would increase the QTc interval more than
sevoﬂurane in patients undergoing liver transplantation.
METHODS
This prospective observational study was a substudy. The parent
study was a randomized controlled clinical trial comparing the
incidence of postreperfusion syndrome between sevoﬂurane and
desﬂurane anesthesia in patients undergoing living-donor liver
transplantation, which was approved by the Institutional Review
Board of Seoul National University Hospital (reference: H-1209-
048-425) and registered at the ClinicalTrials.gov website (reference:
NCT01886664, August 20, 2012). This substudy was also approved
by the Institutional Review Board of Seoul National University
Hospital (reference: H-1209-048-425) and registered at the
ClinicalTrials.gov website (reference: NCT01899248, July 10, 2013).
Written informed consent was obtained from all patients.
The participants were adults aged 18e65 who were scheduled for
elective living-donor liver transplantation. Patients with body mass
index >30 kg$m2, cardiac arrhythmias, severe pulmonary hyper-
tension, intraoperative use of inotropics before reperfusion, intra-
operative cardiac arrest, or a history of liver transplantation were
excluded. In the parent study, patients were randomized using a 1:1
ratio to either sevoﬂurane or desﬂurane groups. Random sequence
of size 2 blocks that included A or B were generated and each
concealed envelope had one letter within. Enrolled patients were
allocated to their groups depending on the letter (A or B) inside the
concealed envelopes that were opened up by an anesthesia nurse
who was unaware of the study.
Anesthetic Management and Surgical Procedure
On arrival in the operating room, patients were monitored using
electrocardiography (ECG), pulse oximetry, and noninvasive bloodpressure measurements. General anesthesia was induced by 40 mg
lidocaine with 2 mg$kg1 propofol and tracheal intubation was
facilitated with 0.6 mg$kg1 rocuronium. After tracheal intubation,
mechanical ventilation was initiated at a tidal volume of 8 mL/kg and
respiratory rateof 10/minusingoxygen/air (fractional inspiredoxygen
0.5). Anesthesia was maintained with sevoﬂurane or desﬂurane, ac-
cording to the group assignment. The inhalation anesthetic was
maintained at 1minimumalveolar concentration (2% for sevoﬂurane
or 7% for desﬂurane) during the operation. Before the anesthesiol-
ogist unaware of the group to which the patient has been randomized,
whowasdesignated tomanage the patient during reperfusion entered
the operating room, the vaporizers on the anesthesia machine were
covered and themonitor settingwas altered to hide the concentration
of the inhalation anesthetic to comply with the double-blind protocol.
Cisatracurium at 0.2 mg$kg1$h1 was infused for neuromuscular
relaxation during the surgery.
The right radial and femoral arteries were cannulated for inva-
sive blood pressure monitoring. Under ultrasound guidance, a 7-Fr
double-lumen central venous catheter (ARROW, Arrow Interna-
tional Inc., Reading, Pa, United States) and a 9-Fr large-bore
catheter (Advanced Venous Access Device, HF, Edwards Life-
sciences, Irvine, Calif, United States) were placed in the right in-
ternal jugular vein. A pulmonary artery catheter (Swan-Ganz
CCOmbo V, Edwards Lifesciences) was inserted into the pulmo-
nary artery through the central venous catheter. The donor liver
graft was preserved with histidine-tryptophan-ketoglutarate solution
(Custodiol, Köhler Chemie GmbH, Alsbach-Hähnlein, Germany).
The surgeon who performed the liver transplantation was blinded to
group assignments. Anastomosis of the liver graft was performed
using the piggyback technique. Just before anastomosis between the
hepatic vein of the graft and the inferior vena cava of the recipient,
the graft was perfused with 5% albumin though the portal vein.
After anastomosis of the portal vein, the graft was reperfused by
release of hepatic vein and portal vein clamps.
The anesthesiologist, who was blinded to group assignments
(vaporizers on the anesthesia machine were covered with aFig 1. Flow diagram for the
study.
Table 1. Characteristics of Patients’ Measured QTc Intervals




(n ¼ 21) P
Age; y 52 (7) 52 (10) .92
Male 15 (68) 17 (81) .36
Height; cm 165.7 (9.4) 165.9 (9.9) .94
Weight; kg 60.9 (8.6) 62.2 (13.0) .7
Body mass index; kg$cm2 22 (2) 22 (4) .72
Underlying disease
Hypertension 1 (5%) 5 (24%) .1
Diabetes 4 (18%) 7 (33%) .31
Chronic obstructive
pulmonary disease
1 (5%) 0 (0) >.99
History of coronary disease 1 (5%) 0 (0) >.99
Chronic kidney disease 0 (0) 1 (5%) .49
Pulmonary hypertension 0 (0) 2 (10%) .23
Etiology of liver disease
Alcoholic 4 (18%) 1 (5%) .35
Nonalcoholic 18 (82%) 21 (95%) .11
MELD score 12 (5%) 12 (5%) .75
Preoperative medication
Beta blocker 2 (9%) 1 (5%) .72
Calcium channel blocker 1 (5%) 3 (15%) .34
Antiarrhythmics 0 (0) 0 (0) >.99
Antibiotics 22 (100%) 21 (100%) >.99
Serum electrolyte levels
Potassium; mmol$L1 4.04 (0.56) 3.99 (0.54) >.99
Calcium; mmol$L1 8.7 (0.41) 8.6 (0.69) .44
Magnesium; mg$dL1 1.73 (0.26) 1.88 (0.17) .2
Preoperative
hemoglobin; g$dL1
11.6 (2.2) 11.3 (2.1) .37
Preoperative QTc interval; ms 453.3 (46.6) 451.3 (38.3) .88
Note: Values are presented as the mean (SD) or number of patients (%).
Abbreviation: MELD, model for end-stage liver disease.
98 MIN, LEE, LEE ET ALblanket), managed the patient according to a standardized protocol
during reperfusion. Postreperfusion syndrome was deﬁned as a
>30% decrease in mean arterial pressure relative to that at initia-
tion of reperfusion lasting more than 1 minute and occurring within
5 minutes of reperfusion. Postreperfusion syndrome was treated
with 5 mg of ephedrine administered intravenously. If the mean
arterial pressure decreased to <40 mm Hg, 10 mg of epinephrine
was administered intravenously. If postreperfusion syndrome
continued, repeated doses of ephedrine or epinephrine were
administered intravenously every minute for 5 minutes. Titrated
infusion of dopamine was administered intravenously if post-
reperfusion syndrome continued despite 5 doses of ephedrine or
epinephrine. The occurrence of postreperfusion syndrome was
recorded.
Anastomosis of the hepatic artery and bile duct were performed
consecutively. All patients were transferred to the intensive care
unit after surgery. The anesthesiologists who managed patients in
the intensive care unit were also blinded to group assignments. The
length of intensive care unit stay was recorded.
QTc Interval
Preoperative QTc intervals were recorded in the ward using a 12-
lead ECG machine. Intraoperative QTc intervals were recorded at
the following time points: before anesthetic induction, before,
immediately after, and at 3, 5, and 10 minutes after trachealintubation, at 5 minutes before and 1, 2, 3, and 20 minutes after
reperfusion, and at skin closure. These time points were expressed
as baseline, pre-intubation, I0, I3, I5, I10, reperfusion-5, R1, R2,
R3, R20, and skin closure, respectively.
Intraoperative QTc intervals were obtained and calculated ac-
cording to the methods in our previous study [15]. In the operating
room, ECG signals were recorded using a continuous monitoring
ECG system (Solar 8000M, GE Medical System, Milwaukee, Wis,
United States). ECG data in lead II were collected with an analog-
to-digital converter (DI-149, DATAQ Instruments Inc., Akron,
Ohio, United States), which was connected to the analog output of
the patient monitor and stored on a personal computer. ECG data
were analyzed using LabChart software (version 6; AD Instruments,
Colorado Springs, Colo, United States). QTc interval was measured
automatically by LabChart software using the ECG curves of 4
consecutive beats to acquire a more accurate representation of the
ECG waveform. If the automatic method did not correctly detect
the onset of the QRS complex or the end of T wave, the QT interval
was measured manually. QT interval measurements were per-
formed by an anesthesiologist who was unaware of group assign-
ment. The QTc interval was calculated using Fridericia’s formula to
preclude interference by heart rate (QTc ¼ QT/RR1/3) [15]. The
mean arterial pressure and heart rate were recorded at the same
time points as the QTc interval (before anesthetic induction, before,
immediately after, and at 5 and 10 minutes after tracheal intuba-
tion, at 5 minutes before and 1, 2, 3, and 20 minutes after reper-
fusion, and at skin closure).
Statistical Analysis
The primary outcome was the maximum QTc interval during 3
minutes after reperfusion. Power analysis indicated that a minimum
of 21 patients would be required for a type 1 error of 0.05 and a
power of 0.8 to detect a difference of 30 ms in QTc interval between
the sevoﬂurane and desﬂurane groups, assuming that the standard
deviation (SD) of the QTc intervals was 34 ms, based on a previous
study [7]. Data on age, weight, height, body mass index, end-stage
liver disease score, serum electrolyte levels, preoperative hemo-
globin, preoperative QTc interval, and length of intensive care unit
stay were compared between groups using Student t test or the
Mann-Whitney U test. Data on gender, underlying disease, preop-
erative medication, etiology of liver disease, and incidence of
postreperfusion syndrome were compared using a c2 test or Fisher
exact test. QTc intervals during anesthesia were compared using
generalized estimating equations. The QTc intervals of reperfusion
and intubation, respectively, were the highest values among those
measured at least 1 minute after each step. The number of patients
whose QTc interval was more than 500 ms was compared using
Fisher exact test. Values are presented as means (SD) or number of
patients (%). SPSS software (version 18.0 for Windows; SPSS Inc.,
Chicago, Ill, United States) was used for all statistical analyses. P
values <.05 were considered to indicate statistical signiﬁcance.RESULTS
The parent study of this substudy was a randomized
controlled clinical trial comparing the incidence of post-
reperfusion syndrome between sevoﬂurane and desﬂurane
anesthesia in patients undergoing living-donor liver trans-
plantation conducted from December 2012 to November
2013. This substudy was a prospective observational study
conducted from January to November 2013. Because of the
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study and this substudy, among 62 patients in the parent
study, 52 patients were enrolled in this study. Of those 52,
complete intraoperative ECG data were available only in 43
patients, and these 43 patients (22 patients in the sevo-
ﬂurane group and 21 patients in the desﬂurane group) were
ﬁnally analyzed (Fig 1).
Serum Electrolyte and Hemodynamic Variable
Patient characteristics did not signiﬁcantly differ between
groups (Table 1). There was also no signiﬁcant difference in
preoperative QTc intervals on ECG, serum electrolyte
levels including calcium, potassium, and magnesium, or the
etiology or severity of the liver disease (Table 1). Intra-
operatively, mean arterial pressure and heart rate at each
study time point were not signiﬁcantly different between the
2 groups (P > .05; Fig 2).
Intraoperative QTc Interval, Intensive Care Unit, and Hospital
Stay
Intraoperative QTc interval changes are shown in Fig 3.
There was no signiﬁcant difference in intraoperative QTc
interval between the 2 groups (P ¼ .59). The maximum QTc
interval during 3 minutes after reperfusion was notFig 2. Intraoperative changes in heart rate (A) and mean arterial pres
pre indicates before, numbers indicate minutes after each step, andsigniﬁcantly different between the sevoﬂurane and des-
ﬂurane groups (452  55 ms and 473  30 ms, respectively;
P ¼ .125). QTc intervals increased signiﬁcantly during
intubation and reperfusion relative to baseline (P ¼ .003
and <.001, respectively). At skin closure, the QTc interval
also increased signiﬁcantly from the baseline (P ¼ .001).
The numbers of patients with QTc intervals >500 ms were
not signiﬁcantly different between the 2 groups during
intubation, reperfusion, and skin closure (Table 2). Among
the 43 patients, postreperfusion syndrome occurred in 24
(55.7%) patients (8 in the sevoﬂurane group, 16 in the
desﬂurane group). Consistent with the parent study, post-
reperfusion syndrome occurred less frequently in the sevo-
ﬂurane group than the desﬂurane group (38.7% vs 77.4%;
P ¼ .014).
However, there were no signiﬁcant differences in the
length of intensive care unit stay (5.4  1.3 vs 6.1  2.6
days; P ¼ .269) or hospital stay (15.5  5.3 vs 18.5  8.4
days; P ¼ .164).DISCUSSION
In this prospective observational study, QTc interval
increased in patients given either sevoﬂurane or desﬂurane
during intubation and reperfusion in living-donor liversure (B) during operation. Abbreviations are for time points, where
I and R stand for intubation and reperfusion, respectively.
Fig 3. Intraoperative changes of corrected QT interval. Abbrevi-
ations are for time points, where pre indicates before, numbers
indicate minutes after each step, and I and R stand for intubation
and reperfusion, respectively.
100 MIN, LEE, LEE ET ALtransplantations. However, there was no signiﬁcant differ-
ence in intraoperative QTc interval prolongation between
the 2 anesthetics at any time point analyzed, including the
peri-intubation and peri-reperfusion periods.
Prolonged preoperative QTc interval has been observed
in approximately half of patients with end-stage liver disease
[5,7,16], and, even in patients whose QTc intervals are
within the normal range, QTc interval is prolonged during
liver transplantation [5]. This corresponds with the result of
our study. In our study, preoperative QTc interval >440 ms
was observed in 9 of patients and QTc interval prolongation
was signiﬁcantly aggravated at the end of surgery compared
with the preoperative value [17,18]. This is because of the
additive effects of risk factors for QTc prolongation, such as
sympathetic stimulation, dynamic hemodynamic changes,
and abrupt electrolyte imbalances during transplantation,
which are associated with life-threatening arrhythmias
[7,16].Table 2. Incidence of Perioperative QTc Interval >500 ms
Baseline Intubation Reperfusion Skin Closure
Sevoﬂurane (n ¼ 22) 0 (0) 0 (0) 5 (23%) 3 (14%)
Desﬂurane (n ¼ 21) 0 (0) 2 (10%) 5 (24%) 2 (10%)
P .489 >.99 >.99
Note: Values are presented as the number of patients (%).Several previous studies observed perioperative QTc
changes in patients with end-stage liver disease [3,19,20];
however, most assessed QTc changes before and after
transplantation. Few studies have observed intraoperative
QTc changes during the risky intraoperative periods.
Therefore, we observed QTc changes within short time
intervals, especially during the peri-intubation and the peri-
reperfusion periods. In previous studies, tracheal intubation
prolonged QTc interval regardless of anesthetic induction
agent [10,21,22]. One possible mechanism of this QTc
prolongation is increased sympatho-adrenal activity caused
by laryngoscopy and stimulation of pharyngeal and laryngeal
nerves during tracheal intubation. Moreover, the peri-
reperfusion period is also a risky period for QTc prolon-
gation because of hemodynamic changes and abrupt
increases in potassium concentrations in the circulating
blood [23]. Consistent with previous results, QTc intervals
during the peri-intubation and the peri-reperfusion periods
were also prolonged in the present study; however, there
was no signiﬁcant difference between the sevoﬂurane and
desﬂurane groups.
Inhalation anesthetics have been reported to prolong the
QTc interval [8e14], and several previous studies have
compared various inhalation agents’ effects on QTc interval
[12e14]. Yildirim et al observed that sevoﬂurane, isoﬂurane,
and desﬂurane all prolonged QTc, QT dispersion, and QTc
dispersion at 3 and 10 minutes after reaching 1 MAC of
end-tidal anesthetic concentration, but there were no sig-
niﬁcant intergroup differences in patients undergoing
noncardiac surgery [13]. In another study comparing effects
on QTc interval during the peri-induction period, QTc in-
terval was more prolonged with desﬂurane than sevoﬂurane,
which was thought to be related to the sympathetic activity
of desﬂurane [14]. Kazanci et al reported no signiﬁcant
difference in QTc dispersion according to anesthetic,
although QT dispersion was more prolonged with des-
ﬂurane than sevoﬂurane anesthesia [12]. However, the study
population in most of these studies included patients
without severe comorbidities. To the best of our knowledge,
this is the ﬁrst report comparing the effects of sevoﬂurane
and desﬂurane on intraoperative QTc prolongation in pa-
tients with end-stage liver disease. The concentration of
inhalation anesthetic is known to be associated with the
degree of QTc interval prolongation regardless of the kinds
of anesthetics [11,24]. Therefore, in our study, we main-
tained 1 minimum alveolar concentration of the inhalation
anesthetics during surgery in both groups. As a result, there
was no signiﬁcant difference between the 2 groups at any
time point although the maximal QTc interval value was
higher in the desﬂurane group than the sevoﬂurane group
during each study period (Fig 3).
This study has several limitations. Because this was a
substudy, the results may not be applicable to patients who
met the exclusion criteria of the parent study (eg, age older
than 65 years, body mass index >30, preoperative cardiac
arrhythmias or severe pulmonary hypertension, intra-
operative use of inotropics before reperfusion, and
SEVOFLURANE AND DESFLURANE 101intraoperative cardiac arrest), and randomization of the
study population in the parent study would not be appli-
cable to our study population. However, several factors
known to affect cardiac outcome, including QTc interval, in
patients with end-stage liver disease (eg, age, gender,
MELD score, Child-Pugh score, liver disease etiology, pre-
operative medication, and preoperative serum electrolyte
levels) were balanced between the groups [19,25,26]. In
addition, the purpose of this study was to compare the 2
kinds of inhalation anesthetics on the QTc interval pro-
longation. Therefore, we maintained 1 minimum alveolar
concentration of the inhalation anesthetics regardless of the
kinds of the inhalation anesthetics.
In conclusion, with respect to intraoperative QTc interval
prolongation, there was no signiﬁcant difference between
sevoﬂurane and desﬂurane anesthesia in patients undergo-
ing elective living-donor liver transplantation. QTc interval
increased relative to preoperative values during intubation
and reperfusion in surgeries using either sevoﬂurane or
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